Neurol. praxi. 2016;17(3):79-86 | DOI: 10.36290/neu.2016.030

Wilsonova nemoc.

doc. MUDr. Robert Rusina, Ph.D.1,2, Mgr. Eva Bolceková1,3
1 Neurologická klinika a Centrum klinických neurověd, 1. LF UK a VFN, Praha
2 Neurologické oddělení, Thomayerova nemocnice, Praha

Cognitive impairment in gastrointestinal and hepatic diseases Cognitive impairment in gastrointestinal disorders is mostly seen in the context of neurological manifestations of Whipple´s disease and as a result of nutrition deficits with hypovitaminosis B1 and B12. Korsakoff´s syndrome usually manifests after diminution of motor manifestations in Wernicke´s encephalopathy and typically presents severe anterograde and retrograde amnesia with confabulations, short term memory and judgement are preserved. Routine assessment of B12 plasmatic levels is no more recommended for dementia screening in general practice. Hepatic encephalopathy may develop in acute liver failure, in portocaval shunt and in hepatic cirrhosis, with two principal forms: manifest hepatic encephalitis with clinical signs and minimal hepatic encephalitis with normal clinical examination but impairment in neuropsychological testing. Wilson´s disease may manifest with neuropsychiatric symptoms, however, cognitive impairment is found only in patient with neurological manifestations of Wilson’s disease.

Keywords: Whipple´s disease, Wernicke´s encephalopathy, Korsakoff´s syndrome, hepatic encephalopathy, hypovitaminosis B12,

Published: August 1, 2016  Show citation

ACS AIP APA ASA Harvard Chicago Chicago Notes IEEE ISO690 MLA NLM Turabian Vancouver
Rusina R, Bolceková E. Wilsonova nemoc. Neurol. praxi. 2016;17(3):79-86. doi: 10.36290/neu.2016.030.
Download citation

References

  1. Acharya JN, Pacheco VH. Neurologic complications of hepatitis C. Neurologist 2008; 14: 151-156. Go to original source... Go to PubMed...
  2. Ba F, Siddiqi ZA. Neurologic complications of bariatric surgery. Rev Neurol Dis 2010; 7: 119-124. Go to PubMed...
  3. Biagi F, Balduzzi D, Delvino P, Schiepatti A, Klersy C, Corazza GR. Prevalence of Whipple's disease in north-western Italy. Eur J Clin Microbiol Infect Dis 2015; 34: 1347-1348. Go to original source...
  4. Christidi F, Kararizou E, Potagas C, Triantafyllou NI, Stamboulis E, Zalonis I. Neurocognitive impairment in Whipple disease with central nervous system involvement. Cogn Behav Neurol 2014; 27: 51-56. Go to original source...
  5. Donovan JP, Schafer DF, Shaw BW Jr, Sorrell MF. Cerebral oedema and increased intracranial pressure in chronic liver disease. Lancet 1998; 351: 719-721. Go to original source...
  6. Dušek P, Brůha R, Burgetová A, Záhoráková D, Růžička E. Wilsonova nemoc. Cesk Slov Neurol N 2013; 76(109): 539-549.
  7. Fenollar F, Puéchal X, Raoult D. Whipple's disease. N Engl J Med 2007; 356: 55-66. Go to original source... Go to PubMed...
  8. Ferenci P, Lockwood A, Mullen K, Tarter R, Weissenborn K, Blei AT. Hepatic encephalopathy - definition, nomenclature, diagnosis, and quantification: final report of the working party at the 1th World Congresses of Gastroenterology, Vienna, 1998. Hepatology 2002; 35: 716-721. Go to original source... Go to PubMed...
  9. Frota NA, Barbosa ER, Porto CS, Lucato LT, Ono CR, Buchpiguel CA, Caramelli P. Cognitive impairment and magnetic resonance imaging correlations in Wilson's disease. Acta Neurol Scand 2013; 127: 391-398. Go to original source... Go to PubMed...
  10. Jones EA, Weissenborn K. Neurology and the liver J Neurol Neurosurg Psychiatry 1997; 63: 279-293. Go to original source...
  11. Health Quality Ontario. Vitamin B12 and cognitive function: an evidence-based analysis. Ont Health Technol Assess Ser 2013; 13: 1-45.
  12. Knopman DS, DeKosky ST, Cummings JL, Chui H, Corey-Bloom J, Relkin N, Small GW, Miller B, Stevens JC. Practice parameter: diagnosis of dementia (an evidence-based review). Report of the Quality Standards Subcommittee of the American Academy of Neurology. Neurology 2001; 56: 1143-1153. Go to original source... Go to PubMed...
  13. Kopelman MD. The Korsakoff syndrome. Br J Psychiatry 1995; 166: 154-173. Go to original source... Go to PubMed...
  14. Kumar N. Neurologic aspects of cobalamin (B12) deficiency. Handb Clin Neurol 2014; 120: 915-926. Go to original source... Go to PubMed...
  15. Lorincz MT. Neurologic Wilson's disease. Ann N Y Acad Sci 2010; 1184: 173-187. Go to original source...
  16. Louis ED, Lynch T, Kaufmann P, Fahn S, Odel J. Diagnostic guidelines in central nervous system Whipple's disease. Ann Neurol 1996; 40: 561-568. Go to original source... Go to PubMed...
  17. Perkin GD, Murray-Lyon I. Neurology and the gastrointestinal system. J Neurol Neurosurg Psychiatry 1998; 65: 291-300. Go to original source...
  18. Sechi G, Serra A. Wernicke's encephalopathy: new clinical settings and recent advances in diagnosis and management. Lancet Neurol 2007; 6: 442-455. Go to original source...
  19. Seniów J, Bak T, Gajda J, Poniatowska R, Czlonkowska A. Cognitive functioning in neurologically symptomatic and asymptomatic forms of Wilson's disease. Mov Disord 2002; 17: 1077-1083. Go to original source... Go to PubMed...
  20. Weissenborn K. The Clinical Relevance of Minimal Hepatic Encephalopathy. A Critical Look. Dig Dis 2015; 33: 555-561. Go to original source... Go to PubMed...




Neurology for Practice

Madam, Sir,
please be aware that the website on which you intend to enter, not the general public because it contains technical information about medicines, including advertisements relating to medicinal products. This information and communication professionals are solely under §2 of the Act n.40/1995 Coll. Is active persons authorized to prescribe or supply (hereinafter expert).
Take note that if you are not an expert, you run the risk of danger to their health or the health of other persons, if you the obtained information improperly understood or interpreted, and especially advertising which may be part of this site, or whether you used it for self-diagnosis or medical treatment, whether in relation to each other in person or in relation to others.

I declare:

  1. that I have met the above instruction
  2. I'm an expert within the meaning of the Act n.40/1995 Coll. the regulation of advertising, as amended, and I am aware of the risks that would be a person other than the expert input to these sites exhibited


No

Yes

If your statement is not true, please be aware
that brings the risk of danger to their health or the health of others.